Keywords
How to Cite
Abstract
The aim of the study was to improve the modern diagnosis of placental dysfunction and its complications.
Materials and methods. The study involved a prospective survey of 70 pregnant women divided into the main group (pregnant women with placental dysfunction) (n = 50) and the control group (n = 20). The main group was divided into subgroups of pregnant women with placental dysfunction and fetal growth retardation (n = 30) and pregnant women with placental dysfunction without fetal growth retardation (n = 20). The control group comprised 20 pregnant women with physiological gestation. Apart from history taking, the study comprised obstetric and general clinical examination, evaluation of endothelium- dependent vasodilation, serum concentrations of soluble forms of vascular and platelet- endothelial molecules of cell adhesion 1, indicators of athrombogenicity of the vascular growth wall, uterine-placental-fetal blood circulation, pathomorphological and histometric examination of the placenta.
Results. Based on the obtained clinical-morphological and endotheliotropic criteria, a personalized clinical algorithm for managing pregnant women with placental dysfunction was developed and implemented.
Conclusions. Assessment of pregnancy results in a prospective clinical study showed that the proposed algorithm for personalization of the risk of perinatal abnormalities not only helped to avoid antenatal mortality, but also to prevent intranatal and early neonatal losses in patients with placental dysfunction and fetal growth retardation.
References
Borzenko I. B. Prediction and early diagnosis of fetal growth retardation in pregnant women with placental dysfunction. – Qualifying scientific paper, manuscript. – Kharkiv National Medical University. – Kharkiv, 2020 – 208 p.
Costa M.A. The endocrine function of human placenta: an overview. 2016. Reproductive BioMedicine Online 32 14–43.
Figueras F, Gratacos E. An integrated approach to fetal growth restriction. Best Pract Res Clin Obstet Gynaecol 2017;38:48e58.
Melnik J.M., Shlyahtina A.A. Early predictors of placental dysfunction. Health of women 2016, 8,25-28.
Tomimatsu T., Mimura K., Endo M., Kumasawa K., Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertension Research. 2017;40(4):305–310.
Ali, S. M., & Khalil, R. A. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. 2015. Expert Opinion on Therapeutic Targets, 19, 1495–1515.
Anderson NH, Sadler LC, McKinlay CJD, McCowan LME. INTERGROWTH-21st vs customized birthweight standards for identification of perinatal mortality and morbidity. Am J Obstet Gynecol 2016;214. 509.e1e7.
Burton GJ, Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. Am J Obstetr Gynecol. 2018;218:S745–61.
Flenady V, Wojcieszek AM, Middleton P, et al. Stillbirths: recall to action in high-income countries. Lancet 2016;387:691e702.
Lewis AJ, Austin E, Galbally M. Prenatal maternal mental health and fetal growth restriction: a systematic review. J Dev Origins Health Dis. 2016;17:1–13.
Menendez-Castro C, Rascher W, Hartner A. Intrauterine growth restriction - impact on cardiovascular diseases later in life. Mol Cell Pediatr. 2018;5:4.
Korzeniewski SJ, Romero R, Chaiworapongsa T, et al. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal caseecohort study. Am J Obstet Gynecol 2016;214. 629.e1e629.e17.
Labarrere, C.A., Dicarlo, H.L., Bammerlin, E. et al, Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. Am J Obstet Gynecol. 2017;216:287.e1–287.e16.
Salavati N, Smies M, Ganzevoort W, Charles AK, Erwich JJ, Plösch T and Gordijn SJ. The Possible Role of Placental Morphometry in the Detection of Fetal Growth Restriction. Front. Physiol. 2019. 9:1884.
Rabinovich A, Tsemach T, Novack L, et al. Late preterm and early term: when to induce a growth restricted fetus? A population-based study. J Matern Fetal Neonatal Med 2017 Mar 22:1e7.
Gaccioli, F., Lager, S. Placental nutrient transport and intrauterine growth restriction. Front Physiol. 2016;7:40.
Sharma et al. Intrauterine growth restriction: antenatal and postnatal aspects. Clinical Medicine Insights: Pediatrics 2016:10 67–83.
Baschat AA. Planning management and delivery of the growth-restricted fetus. Best Pract Res Clin Obstetr Gynaecol. 2018;49:53–65.
Cuckle H, Maymon R. Development of prenatal screening e a historical overview. Semin Perinatol 2016;40:12e22.
Eloundou SN, Lee J, Wu D, Lei J, Feller MC, Ozen M, et al. Placental malperfusion in response to intrauterine inflammation and its connection to fetal sequelae. PLoS ONE 2019;14(4): e0214951
Ernst SA, Brand T, Reeske A, Spallek J, Petersen K, Zeeb H. Care-related and maternal risk factors associated with the antenatal nondetection of intrauterine growth restriction: a case-control study from Bremen, Germany. BioMed Res Int. 2017;2017:1746146.
"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.